KLK3 and prostate carcinoma: In this study, 90% of total mortality occurred in men with PSA > 2 ng/mL, whereas men with PSA < 1 ng/mL had 0.5% risk of metastasis and 0.2% risk of death from prostate cancer by the age of 85.